UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Paradigm Financial Partners LLC

Paradigm Financial Partners LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 12,737 shares of the healthcare conglomerate’s stock after buying an additional 125 shares during the period. UnitedHealth Group accounts for 1.6% of Paradigm Financial Partners LLC’s portfolio, making the stock its 11th biggest holding. Paradigm Financial Partners LLC’s holdings in UnitedHealth Group were worth $6,705,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Sargent Investment Group LLC grew its holdings in UnitedHealth Group by 10.5% during the fourth quarter. Sargent Investment Group LLC now owns 2,857 shares of the healthcare conglomerate’s stock valued at $1,504,000 after purchasing an additional 271 shares during the period. Stonebrook Private Inc. acquired a new stake in UnitedHealth Group during the 4th quarter worth $1,488,000. Omnia Family Wealth LLC grew its stake in UnitedHealth Group by 45.7% in the fourth quarter. Omnia Family Wealth LLC now owns 603 shares of the healthcare conglomerate’s stock valued at $317,000 after acquiring an additional 189 shares during the period. Principle Wealth Partners LLC raised its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. Principle Wealth Partners LLC now owns 7,530 shares of the healthcare conglomerate’s stock worth $3,964,000 after purchasing an additional 119 shares during the period. Finally, Transcend Capital Advisors LLC grew its position in shares of UnitedHealth Group by 2.2% in the 4th quarter. Transcend Capital Advisors LLC now owns 8,351 shares of the healthcare conglomerate’s stock valued at $4,396,000 after purchasing an additional 179 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Insider Buying and Selling at UnitedHealth Group

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

UnitedHealth Group Trading Up 0.3 %

Shares of UNH stock traded up $1.49 during trading hours on Friday, hitting $495.35. 2,727,016 shares of the company’s stock traded hands, compared to its average volume of 5,623,667. The stock has a market cap of $455.76 billion, a PE ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock’s 50 day simple moving average is $485.84 and its 200 day simple moving average is $514.14. The company has a quick ratio of 0.79, a current ratio of 0.85 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the firm earned $6.26 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 45.97%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on UNH shares. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. HSBC upgraded shares of UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a report on Thursday, April 4th. Barclays boosted their price target on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a report on Friday, April 19th. Finally, Stephens reissued an “overweight” rating and issued a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.